Laboratory Testing - what we need and what we don't?

被引：9

作者：

Moeckel, Martin ^{[1
,2
,3
]}

Mueller, Christian ^{[4
,5
]}

Lindner, Tobias ^{[6
,7
]}

Searle, Julia ^{[7
,8
]}

机构：

[1] Campus Virchow Klinikums, Arbeitsbereichs Notfallmed Rettungsstellen Aufnah, Berlin, Germany

[2] Campus Virchow Klinikums, Chest Pain Units, Berlin, Germany

[3] Campus Charite Mitte, Berlin, Germany

[4] Charite, Zent Lab, Berlin, Germany

[5] Charite, Forsch Grp Arbeitsbereiches Notfallmed, Berlin, Germany

[6] Charite, Chirurg & Unfallchirurg Orthopadie Klin Notfall &, Berlin, Germany

[7] Charite, Arbeitsbereiches Notfallmed, Berlin, Germany

[8] Charite, Bereich Forsch, Berlin, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2016年 / 141卷 / 05期

关键词：

EMERGENCY-DEPARTMENT; PROCALCITONIN; DIAGNOSIS; GUIDELINES; MANAGEMENT; OUTCOMES; SOCIETY; SEPSIS; IDENTIFICATION; DISORDERS;

D O I：

10.1055/s-0041-109207

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Laboratory parameters in emergency medicine can be divided into 3 categories. Urgent obligatory parameters are necessary for immediate therapeutic decisions and must be available within 60 minutes. For these, testing in the emergency department (ED) as point-of-care-testing (POCT) should be considered. The second category are obligatory parameters which require diagnostic/therapeutic consequences in the emergency department, but are not necessary for immediate life-saving actions. Due to international consensus of a 4-hour length of stay target for ED, results should be available within this time. The third category are parameters which do not lead to immediate diagnostic or therapeutic consequences, but are important for process management and patient flow in the ED. They should therefore be available as emergency tests. POC-testing should be used for a limited number of very urgent parameters and should be organized as a satellite laboratory in cooperation with the central laboratory.

引用

页码：322 / +

页数：9

共 50 条

[31] Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: What we know, what we don't know, and what we need to know
Klaus-Peter Hunfeld
Volker Brade
Wiener klinische Wochenschrift, 2006, 118 : 659 - 668
[32] Familial hematurias: what we know and what we don't
Kashtan, CE
PEDIATRIC NEPHROLOGY, 2005, 20 (08) : 1027 - 1035
[33] Milk lipidomics: What we know and what we don't
Liu, Zhiqian
Rochfort, Simone
Cocks, Ben
PROGRESS IN LIPID RESEARCH, 2018, 71 : 70 - 85
[34] Garlic - What we know and what we don't know
Charlson, Mary
McFerren, Marcus
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (04) : 325 - 326
[35] Melatonin in plants: what we know and what we don't
Zhang, Zixin
Zhang, Yang
FOOD QUALITY AND SAFETY, 2021, 5
[36] The officer of arms: What we know and what we don't
Paravicini, Werner
REVUE DU NORD, 2006, 88 (366-67) : 467 - +
[37] Sick buildings: What we know, what we don't
不详
ASHRAE JOURNAL-AMERICAN SOCIETY OF HEATING REFRIGERATING AND AIR-CONDITIONING ENGINEERS, 1995, 37 (12): : 10 - &
[38] The sugarcane genome: What we know and what we don't
Burnquist, WL
INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL I, PROCEEDINGS, 2001, : 29 - 33
[39] Candida pneumonia: What we know and what we don't
Barkauskas C.E.
Perfect J.R.
Current Fungal Infection Reports, 2009, 3 (1) : 21 - 31
[40] What do we know and what don't we know?
Fawcett, J
PSYCHIATRIC ANNALS, 2006, 36 (01) : 5 - 6

← 1 2 3 4 5 →